Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 6kWORD 18k
7 December 2018
E-005154/2018(ASW)
Answer given by President Juncker on behalf of the European Commission
Question reference: E-005154/2018

In its reply to Written Question P-003774/2018 the Commission stated that as it is represented on the Management Board of the European Medicines Agency, it closely follows the Agency's proposed measures to mitigate the related business continuity risks arising from its relocation to Amsterdam.

The Board was informed on 4 October 2018 that cooperation with the Netherlands is running smoothly and preparations for the interim and the permanent buildings are on track.

This and other information on Brexit preparedness is available on the Agency's website. In addition, as of three months following the entry into force of the Agency's amended Regulation, the Netherlands will be required to report on progress on the building to the European Parliament and Council.

As stipulated by the co-legislators in a recital to the regulation amending the Agency's Regulation, ‘the authorities of the Netherlands are making efforts to ensure the operational effectiveness, continuity and uninterrupted functioning of the Agency during and after the relocation. Nevertheless, given the extraordinary situation, the Agency may have to temporarily focus on its core tasks and prioritise other activities according to their impact on public health and the Agency's ability to function.’

The Agency is working closely with the Commission on the prioritisation of activities, in order to ensure protection of public health in the European Union.

The Commission has sent the Agency the request of the Honourable Members on costs related to its move from London to Amsterdam. The Commission will transmit the reply as soon as possible.

Last updated: 7 December 2018Legal notice